International Histopathology Consensus for Unilateral Primary Aldosteronism.


Journal

The Journal of clinical endocrinology and metabolism
ISSN: 1945-7197
Titre abrégé: J Clin Endocrinol Metab
Pays: United States
ID NLM: 0375362

Informations de publication

Date de publication:
01 01 2021
Historique:
received: 10 06 2020
accepted: 20 07 2020
pubmed: 28 7 2020
medline: 4 9 2021
entrez: 28 7 2020
Statut: ppublish

Résumé

Develop a consensus for the nomenclature and definition of adrenal histopathologic features in unilateral primary aldosteronism (PA). Unilateral PA is the most common surgically treated form of hypertension. Morphologic examination combined with CYP11B2 (aldosterone synthase) immunostaining reveals diverse histopathologic features of lesions in the resected adrenals. Surgically removed adrenals (n = 37) from 90 patients operated from 2015 to 2018 in Munich, Germany, were selected to represent the broad histologic spectrum of unilateral PA. Five pathologists (Group 1 from Germany, Italy, and Japan) evaluated the histopathology of hematoxylin-eosin (HE) and CYP11B2 immunostained sections, and a consensus was established to define the identifiable features. The consensus was subsequently used by 6 additional pathologists (Group 2 from Australia, Brazil, Canada, Japan, United Kingdom, United States) for the assessment of all adrenals with disagreement for histopathologic diagnoses among group 1 pathologists. Consensus was achieved to define histopathologic features associated with PA. Use of CYP11B2 immunostaining resulted in a change of the original HE morphology-driven diagnosis in 5 (14%) of 37 cases. Using the consensus criteria, group 2 pathologists agreed for the evaluation of 11 of the 12 cases of disagreement among group 1 pathologists. The HISTALDO (histopathology of primary aldosteronism) consensus is useful to standardize nomenclature and achieve consistency among pathologists for the histopathologic diagnosis of unilateral PA. CYP11B2 immunohistochemistry should be incorporated into the routine clinical diagnostic workup to localize the likely source of aldosterone production.

Identifiants

pubmed: 32717746
pii: 5876946
doi: 10.1210/clinem/dgaa484
pmc: PMC7765663
doi:

Substances chimiques

Cytochrome P-450 CYP11B2 EC 1.14.15.4

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Validation Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

42-54

Subventions

Organisme : BLRD VA
ID : I01 BX004681
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK106618
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL144847
Pays : United States
Organisme : NIGMS NIH HHS
ID : U54 GM115428
Pays : United States

Informations de copyright

© The Author(s) 2020. Published by Oxford University Press on behalf of the Endocrine Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Références

Hypertension. 2020 Mar;75(3):634-644
pubmed: 31957522
Hypertension. 2010 Nov;56(5):885-92
pubmed: 20937967
Steroids. 1995 Jan;60(1):35-41
pubmed: 7792813
Clin Endocrinol (Oxf). 2015 May;82(5):639-47
pubmed: 25347939
Horm Metab Res. 2017 Dec;49(12):957-962
pubmed: 29202495
Mol Cell Endocrinol. 2014 Jul 5;392(1-2):73-9
pubmed: 24837548
Clin Endocrinol Metab. 1985 Nov;14(4):791-820
pubmed: 3002677
Hypertension. 2018 Sep;72(3):650-657
pubmed: 30012870
Eur J Endocrinol. 2018 Jul;179(1):R19-R29
pubmed: 29674485
Lancet. 1992 Jul 18;340(8812):159-61
pubmed: 1352575
Pathol Int. 2017 Apr;67(4):214-221
pubmed: 28261922
J Clin Endocrinol Metab. 2010 May;95(5):2296-305
pubmed: 20200334
Mol Cell Endocrinol. 2014 Mar 5;383(1-2):111-7
pubmed: 24325867
J Clin Endocrinol Metab. 2012 May;97(5):E819-29
pubmed: 22442279
Endocr Rev. 2018 Dec 1;39(6):1029-1056
pubmed: 30007283
Mol Cell Endocrinol. 2015 Aug 15;411:146-54
pubmed: 25958045
Lancet Diabetes Endocrinol. 2017 Sep;5(9):689-699
pubmed: 28576687
Physiol Rev. 2016 Oct;96(4):1327-84
pubmed: 27535640
Lancet Diabetes Endocrinol. 2018 Jan;6(1):41-50
pubmed: 29129575
J Clin Endocrinol Metab. 2016 May;101(5):1889-916
pubmed: 26934393
J Clin Endocrinol Metab. 2017 Apr 1;102(4):1182-1192
pubmed: 28388725
J Clin Endocrinol Metab. 2020 Mar 1;105(3):
pubmed: 31789380
Hypertension. 2018 Sep;72(3):632-640
pubmed: 30354756
Lancet Diabetes Endocrinol. 2018 Jan;6(1):51-59
pubmed: 29129576
Nat Rev Endocrinol. 2013 Feb;9(2):104-12
pubmed: 23229280
Hypertension. 2018 Oct;72(4):874-880
pubmed: 30354720
Hypertension. 2015 Nov;66(5):1014-22
pubmed: 26351028
J Clin Endocrinol Metab. 2016 Jan;101(1):6-9
pubmed: 26580238
Proc Natl Acad Sci U S A. 2015 Aug 18;112(33):E4591-9
pubmed: 26240369
J Clin Pathol. 2013 Apr;66(4):351-4
pubmed: 23436930

Auteurs

Tracy Ann Williams (TA)

Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, Ludwig-Maximilians-Universität München, Germany.
Division of Internal Medicine and Hypertension, Department of Medical Sciences, University of Turin, Turin, Italy.

Celso E Gomez-Sanchez (CE)

Endocrine Division, G.V. (Sonny) Montgomery VA Medical Center, and Department of Pharmacology and Toxicology and Medicine, University of Mississippi Medical Center, Jackson, MS, USA.

William E Rainey (WE)

Department of Molecular and Integrative Physiology, University of Michigan, Ann Arbor, MI, USA.
Division of Metabolism, Endocrine, and Diabetes, Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA.

Thomas J Giordano (TJ)

Division of Metabolism, Endocrine, and Diabetes, Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA.
Department of Pathology and Rogel Cancer Center, University of Michigan, Ann Arbor, MI, USA.

Alfred K Lam (AK)

School of Medicine, Griffith University, Gold Coast, Australia.

Alison Marker (A)

Department of Histopathology, Cambridge University NHS Foundation Trust, Cambridge, UK.

Ozgur Mete (O)

Department of Pathology, University Health Network, Toronto, Canada.
Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada.

Yuto Yamazaki (Y)

Department of Pathology, Tohoku University Graduate School of Medicine, Sendai, Japan.

Maria Claudia Nogueira Zerbini (MCN)

Departamento de Patologia, Faculdade de Medicina da Universidade de Sao Paulo, Sao Paulo, Brazil.

Felix Beuschlein (F)

Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, Ludwig-Maximilians-Universität München, Germany.
Klinik für Endokrinologie, Diabetologie und Klinische Ernährung, Universitätsspital Zürich, Zürich, Switzerland.

Fumitoshi Satoh (F)

Division of Clinical Hypertension, Endocrinology and Metabolism, Tohoku University Graduate School of Medicine, Sendai, Japan.

Jacopo Burrello (J)

Division of Internal Medicine and Hypertension, Department of Medical Sciences, University of Turin, Turin, Italy.

Holger Schneider (H)

Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, Ludwig-Maximilians-Universität München, Germany.

Jacques W M Lenders (JWM)

Department of Internal Medicine, Radboud University Medical Center, Nijmegen, The Netherlands.
Department of Medicine III, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany.

Paolo Mulatero (P)

Division of Internal Medicine and Hypertension, Department of Medical Sciences, University of Turin, Turin, Italy.

Isabella Castellano (I)

Division of Pathology, Department of Medical Sciences, University of Turin, Turin, Italy.

Thomas Knösel (T)

Institute of Pathology, Ludwig-Maximilians-Universität München, Germany.

Mauro Papotti (M)

Department of Oncology, University of Turin, Turin, Italy.

Wolfgang Saeger (W)

Institute of Pathology, Universität Hamburg, Germany.

Hironobu Sasano (H)

Department of Pathology, Tohoku University Graduate School of Medicine, Sendai, Japan.

Martin Reincke (M)

Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, Ludwig-Maximilians-Universität München, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH